CRISPR Therapeutics AG Statistics
Total Valuation
CRSP has a market cap or net worth of $3.08 billion. The enterprise value is $1.40 billion.
Important Dates
The last earnings date was Tuesday, May 6, 2025, after market close.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CRSP has 86.36 million shares outstanding. The number of shares has increased by 6.74% in one year.
| Current Share Class | 86.36M |
| Shares Outstanding | 86.36M |
| Shares Change (YoY) | +6.74% |
| Shares Change (QoQ) | +0.56% |
| Owned by Insiders (%) | 0.47% |
| Owned by Institutions (%) | 73.50% |
| Float | 85.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 80.74 |
| Forward PS | 37.93 |
| PB Ratio | 1.58 |
| P/TBV Ratio | 1.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 37.06 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -13.25% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | $95,865 |
| Profits Per Employee | -$981,316 |
| Employee Count | 393 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CRSP has paid $3.97 million in taxes.
| Income Tax | 3.97M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.16% in the last 52 weeks. The beta is 1.87, so CRSP's price volatility has been higher than the market average.
| Beta (5Y) | 1.87 |
| 52-Week Price Change | -33.16% |
| 50-Day Moving Average | 38.67 |
| 200-Day Moving Average | 44.67 |
| Relative Strength Index (RSI) | 44.75 |
| Average Volume (20 Days) | 2,024,196 |
Short Selling Information
The latest short interest is 21.32 million, so 24.69% of the outstanding shares have been sold short.
| Short Interest | 21.32M |
| Short Previous Month | 20.76M |
| Short % of Shares Out | 24.69% |
| Short % of Float | 24.80% |
| Short Ratio (days to cover) | 9.07 |
Income Statement
In the last 12 months, CRSP had revenue of $37.68 million and -$385.66 million in losses. Loss per share was -$4.52.
| Revenue | 37.68M |
| Gross Profit | -400.08M |
| Operating Income | -474.40M |
| Pretax Income | -263.15M |
| Net Income | -385.66M |
| EBITDA | -455.16M |
| EBIT | -474.40M |
| Loss Per Share | -$4.52 |
Full Income StatementBalance Sheet
The company has $1.90 billion in cash and $223.69 million in debt, giving a net cash position of $1.68 billion or $19.45 per share.
| Cash & Cash Equivalents | 1.90B |
| Total Debt | 223.69M |
| Net Cash | 1.68B |
| Net Cash Per Share | $19.45 |
| Equity (Book Value) | 1.93B |
| Book Value Per Share | 22.53 |
| Working Capital | n/a |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -1,259.20% |
| Pretax Margin | -1,013.10% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |